Literature DB >> 11490343

Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma.

K M McMasters1, S L Wong, M J Edwards, M I Ross, C Chao, R D Noyes, V Viar, P B Cerrito, D S Reintgen.   

Abstract

BACKGROUND: This analysis was performed to identify prognostic factors that are predictive of sentinel lymph node (SLN) metastasis in melanoma.
METHODS: Analysis was performed of a multi-institutional, prospective, randomized trial of SLN biopsy for melanoma. Eligibility criteria included age 18 to 70 years, Breslow thickness of 1.0 mm or more, and clinically negative regional lymph nodes. SLNs were evaluated by serial sectioning and immunohistochemistry for S100. Univariate chi-square and multivariate logistic regression analyses were performed to assess factors predictive of the presence of a positive SLN. Probability values of less than.05 were considered significant.
RESULTS: SLNs were identified in 99.7% of patients. A total of 1058 patients were evaluated; 961 patients had complete data and were included in the statistical analysis. SLNs were positive for tumor in 208 of 961 patients (22%). Breslow thickness, Clark level, ulceration, and patient age were factors that were found to be independently predictive of the presence of SLN metastasis.
CONCLUSIONS: Increasing Breslow thickness, Clark level of more than III, the presence of ulceration, and patient age of 60 years or less are the most important independent prognostic factors associated with the finding of positive SLN in patients with melanoma.

Entities:  

Mesh:

Year:  2001        PMID: 11490343     DOI: 10.1067/msy.2001.115830

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  18 in total

1.  Gender-related differences in outcome for melanoma patients.

Authors:  Charles R Scoggins; Merrick I Ross; Douglas S Reintgen; R Dirk Noyes; James S Goydos; Peter D Beitsch; Marshall M Urist; Stephan Ariyan; Jeffrey J Sussman; Michael J Edwards; Anees B Chagpar; Robert C G Martin; Arnold J Stromberg; Lee Hagendoorn; Kelly M McMasters
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

2.  Sentinel lymph node biopsies in cancers of the skin, colon, head and neck, and breast.

Authors:  Bridget M Nelson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-04

3.  Laparoscopic iliac and iliofemoral lymph node resection for melanoma.

Authors:  Don Hoang; Kurt E Roberts; Edward Teng; Deepak Narayan
Journal:  Surg Endosc       Date:  2012-08-12       Impact factor: 4.584

4.  Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database.

Authors:  Richard L White; Gregory D Ayers; Virginia H Stell; Shouluan Ding; Jeffrey E Gershenwald; Jonathan C Salo; Barbara A Pockaj; Richard Essner; Mark Faries; Kim James Charney; Eli Avisar; Axel Hauschild; Friederike Egberts; Bruce J Averbook; Carlos A Garberoglio; John T Vetto; Merrick I Ross; David Chu; Vijay Trisal; Harald Hoekstra; Eric Whitman; Harold J Wanebo; Daniel Debonis; Michael Vezeridis; Aaron Chevinsky; Mohammed Kashani-Sabet; Yu Shyr; Lynne Berry; Zhiguo Zhao; Seng-Jaw Soong; Stanley P L Leong
Journal:  Ann Surg Oncol       Date:  2011-06-07       Impact factor: 5.344

Review 5.  Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

Authors:  Dale Han; Daniel C Thomas; Jonathan S Zager; Barbara Pockaj; Richard L White; Stanley Pl Leong
Journal:  World J Clin Oncol       Date:  2016-04-10

6.  Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival.

Authors:  Faruk Tas; Kayhan Erturk
Journal:  Mol Clin Oncol       Date:  2017-10-04

7.  Validation of statistical predictive models meant to select melanoma patients for sentinel lymph node biopsy.

Authors:  Michael S Sabel; John D Rice; Kent A Griffith; Lori Lowe; Sandra L Wong; Alfred E Chang; Timothy M Johnson; Jeremy M G Taylor
Journal:  Ann Surg Oncol       Date:  2011-08-06       Impact factor: 5.344

8.  Melanoma sentinel node biopsy and prediction models for relapse and overall survival.

Authors:  A Mitra; C Conway; C Walker; M Cook; B Powell; S Lobo; M Chan; M Kissin; G Layer; J Smallwood; C Ottensmeier; P Stanley; H Peach; H Chong; F Elliott; M M Iles; J Nsengimana; J H Barrett; D T Bishop; J A Newton-Bishop
Journal:  Br J Cancer       Date:  2010-09-21       Impact factor: 7.640

9.  [Sentinel lymph node in melanoma].

Authors:  T Meyer; M Möhrle; C Garbe; W Hohenberger
Journal:  Chirurg       Date:  2004-08       Impact factor: 0.955

Review 10.  [Malignant head and neck melanoma: Part 2: Therapy].

Authors:  C Pföhler; T Vogt; C S L Müller
Journal:  HNO       Date:  2015-08       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.